StonvexLoading…
StonvexStonvexStonvexCore line items from AMAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $422.23M | $401.30M | $358.08M | $258.49M |
Operating Income | $140.16M | $145.59M | $124.73M | $108.16M |
Net Income | $104.45M | $106.43M | $87.98M | $81.48M |
EPS (Diluted) | $3.41 | $3.44 | $2.86 | $2.61 |
Total Assets | $8.87B | $8.26B | $7.97B | $7.84B |
Total Liabilities | $8.08B | $7.55B | $7.39B | $7.33B |
Cash & Equivalents | $291.22M | $60.75M | $90.57M | $63.54M |
Free Cash Flow OCF − CapEx | $134.40M | $122.29M | $115.75M | $145.65M |
Shares Outstanding | 29.82M | 30.67M | 30.43M | 30.70M |